Abstract:The 70-kDa heat shock protein (HSP70) family of molecular chaperones represents one of the most ubiquitous classes of chaperones and is highly conserved in all organisms. Members of the HSP70 family control all aspects of cellular proteostasis such as nascent protein chain folding, protein import into organelles, recovering of proteins from aggregation, and assembly of multi-protein complexes. These chaperones augment organismal survival and longevity in the face of proteotoxic stress by enhancing cell viability and facilitating protein damage repair. Extracellular HSP70s have a number of cytoprotective and immunomodulatory functions, the latter either in the context of facilitating the cross-presentation of immunogenic peptides via major histocompatibility complex (MHC) antigens or in the context of acting as “chaperokines” or stimulators of innate immune responses. Studies have linked the expression of HSP70s to several types of carcinoma, with Hsp70 expression being associated with therapeutic resistance, metastasis, and poor clinical outcome. In malignantly transformed cells, HSP70s protect cells from the proteotoxic stress associated with abnormally rapid proliferation, suppress cellular senescence, and confer resistance to stress-induced apoptosis including protection against cytostatic drugs and radiation therapy. All of the cellular activities of HSP70s depend on their adenosine-5′-triphosphate (ATP)-regulated ability to interact with exposed hydrophobic surfaces of proteins. ATP hydrolysis and adenosine diphosphate (ADP)/ATP exchange are key events for substrate binding and Hsp70 release during folding of nascent polypeptides. Several proteins that bind to distinct subdomains of Hsp70 and consequently modulate the activity of the chaperone have been identified as HSP70 co-chaperones. This review focuses on the regulation, function, and relevance of the molecular Hsp70 chaperone machinery to disease and its potential as a therapeutic target.

The multifunction of HSP70 in cancer: Guardian or traitor to the survival of tumor cells and the next potential therapeutic target

HSP70 Multi-Functionality in Cancer

HSP70 Family in Cancer: Signaling Mechanisms and Therapeutic Advances

Hsp70 in cancer: A double agent in the battle between survival and death

Membrane heat shock protein 70: a theranostic target for cancer therapy

Targeting HSP90 as a Novel Therapy for Cancer: Mechanistic Insights and Translational Relevance

Targeting HSP70: The second potentially druggable heat shock protein and molecular chaperone?

Message in a bottle: role of the 70-kDa heat shock protein family in anti-tumor immunity

Mechanisms of Action of HSP110 and Its Cognate Family Members in Carcinogenesis

HSP70 and HSP90 in Cancer: Cytosolic, Endoplasmic Reticulum and Mitochondrial Chaperones of Tumorigenesis

The human HSP70 family of chaperones: where do we stand?

Heat Shock Proteins, a Double-Edged Sword: Significance in Cancer Progression, Chemotherapy Resistance and Novel Therapeutic Perspectives

Targeting Heat-Shock Protein 90 in Cancer: An Update on Combination Therapy

HSP90 and the chaperoning of cancer

The heat-shock, or HSF1-mediated proteotoxic stress, response in cancer: from proteomic stability to oncogenesis

The Molecular Chaperone Heat Shock Protein 70 Controls Liver Cancer Initiation and Progression by Regulating Adaptive DNA Damage and Mitogen-Activated Protein Kinase/Extracellular Signal-Regulated Kinase Signaling Pathways

The Interplay between Heat Shock Proteins and Cancer Pathogenesis: A Novel Strategy for Cancer Therapeutics

Heat shock proteins in hepatocellular carcinoma: Molecular mechanism and therapeutic potential

HSP90 inhibitors and cancer: Prospects for use in targeted therapies (Review)

Heat shock protein paradigms in cancer progression: future therapeutic perspectives

Targeting Heat Shock Proteins in Cancer: A Promising Therapeutic Approach